Structural biology of complement receptors

Front Immunol. 2023 Sep 11:14:1239146. doi: 10.3389/fimmu.2023.1239146. eCollection 2023.

Abstract

The complement system plays crucial roles in a wide breadth of immune and inflammatory processes and is frequently cited as an etiological or aggravating factor in many human diseases, from asthma to cancer. Complement receptors encompass at least eight proteins from four structural classes, orchestrating complement-mediated humoral and cellular effector responses and coordinating the complex cross-talk between innate and adaptive immunity. The progressive increase in understanding of the structural features of the main complement factors, activated proteolytic fragments, and their assemblies have spurred a renewed interest in deciphering their receptor complexes. In this review, we describe what is currently known about the structural biology of the complement receptors and their complexes with natural agonists and pharmacological antagonists. We highlight the fundamental concepts and the gray areas where issues and problems have been identified, including current research gaps. We seek to offer guidance into the structural biology of the complement system as structural information underlies fundamental and therapeutic research endeavors. Finally, we also indicate what we believe are potential developments in the field.

Keywords: C5aR1/C5L2/C3aR; CR1/CR2; CR3/CR4; CRIg; complement; complement receptors; host-pathogen interactions; structural biology.

Publication types

  • Review

Grants and funding

This work was funded by Grants PDC2022-133713-I00 of the Spanish Ministerio de Ciencia e Innovación-Recovery, Transformation and Resilience Plan (PRTR), S2022/BMD-7278 of the Regional Government of Madrid, and the European Commission – NextGenerationEU through CSIC’s Global Health Platform (“PTI Salud Global”) (SGL2103020) (to MCV), and the CSIC Special Intramural Grant PIE-201620E064 (to MCV). It was additionally supported by the Network of Excellence Complement in Health and Disease (RED2022-134750-T). KdlP was supported by the Industrial Ph.D. Doctorate (DIN2018-010094) of the Spanish Ministry of Economy and Innovation.